Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Changes in Spatiotemporal Gait Parameters During a Digitally Assisted Self-rehabilitation Program for Elderly Fallers ( DigiWalk ) (DigiWalk)

3. august 2026 opdateret af: University Hospital, Angers

Falls are a health issue that is both common among older adults (affecting 1 in 2 people each year after age 80) and serious due to their traumatic, psychological, and functionally disabling complications. The international literature shows that it is possible to prevent recurrent falls by addressing the risk factors for falls, particularly by combating a sedentary lifestyle and deconditioning through regular standing and mobility exercises as part of a rehabilitation program. As part of France's major national plan to prevent falls among older adults, and at a time when medicine is becoming increasingly personalized, prescribing a digitally assisted self-rehabilitation program for people over 65 following a fall could enable as many people as possible to benefit from rehabilitation that boosts their motivation and reduces the time spent by healthcare professionals, while ensuring high-quality follow-up care.

LNA Santé, in collaboration with the Angers and Nantes University Hospitals, has developed a personalized, digitally assisted fall prevention program (the Stand'hop app) comprising three types of activities: tailored physical exercises, structured lifestyle advice, and an objective measurement of the patient's physical activity. Before moving forward with a larger-scale clinical trial to evaluate the effectiveness of this personalized, digitally assisted fall prevention program, the present study DigiWalk aims to describe changes in walking performance over 7 weeks among older adults who have experienced falls, when the program is used as an adjunct to standard care, compared to changes observed in older adults who have experienced falls and receive only standard care.

Studieoversigt

Status

Ikke rekrutterer endnu

Detaljeret beskrivelse

The main objective is to compare changes in spatiotemporal gait parameters, after 7 weeks of intervention, in :

  • Elderly fallers with a digitally assisted self-rehabilitation program in addition to standard care
  • Elderly fallers with standard rehabilitation care

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

200

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Patients aged 65 and older Fall at least once in the previous 3 months , requiring rehabilitation care from a physical therapist
  • Signed informed consent or consent from a third party (trusted individual, family member, or close relative)
  • Individuals physically capable of following a rehabilitation program (standard care, with or without digital assistance) and of wearing a watch
  • Individuals capable of following a self-rehabilitation program as well as the study procedures independently or with the assistance of a caregiver if needed
  • Patients enrolled in or covered by a social security program

Exclusion Criteria:

  • A person deprived of liberty by an administrative or judicial decision, a person undergoing involuntary psychiatric treatment, or an adult subject to a legal protective measure
  • Contraindications to rehabilitation programs offered following a fall (standard care, with or without digital assistance)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Sham-komparator: Kontrolgruppe
Standard rehabilitation care
Aktiv komparator: Interventionsgruppe
Digitally assisted self-rehabilitation program in addition to standard care using Personalized Fall Prevention Program (PFPP) through the Stand'hop app.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Changes in the spatiotemporal gait parameters between V1 and V3 : stride length Spatiotemporal gait parameters as measured using GAITRite®
Tidsramme: this outcome is assessed at baseline and 7 weeks (8 weeks maximum)
this outcome is assessed at baseline and 7 weeks (8 weeks maximum)
Changes in the spatiotemporal gait parameters between V1 and V3 : Percentage of double support time Spatiotemporal gait parameters as measured using GAITRite®
Tidsramme: this outcome is assessed at baseline and 7 weeks (8 weeks maximum)
this outcome is assessed at baseline and 7 weeks (8 weeks maximum)
Changes in the spatiotemporal gait parameters between V1 and V3 : Coefficient of variation of stride time Spatiotemporal gait parameters as measured using GAITRite®
Tidsramme: this outcome is assessed at baseline and 7 weeks (8 weeks maximum)
this outcome is assessed at baseline and 7 weeks (8 weeks maximum)
Walking speed (km/h).
Tidsramme: this outcome is assessed at baseline and 7 weeks (8 weeks maximum)
Walking speed (km/h). Spatiotemporal gait parameters as measured using GAITRite®
this outcome is assessed at baseline and 7 weeks (8 weeks maximum)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Number of falls
Tidsramme: baseline, 3 weeks and 7 weeks (8 maximum)
baseline, 3 weeks and 7 weeks (8 maximum)
Gait stability measured by a smartwatch paired with an iPhone (in percentage)
Tidsramme: 1 week and 7 weeks (8 weeks max)
Apple Healthkiit / appleWalkingSteadiness : Samples that match the Walking Steadiness identifier use percentage units (described in HKUnit)
1 week and 7 weeks (8 weeks max)
Time spent performing activities involving whole-body movements (minutes), measured by a smartwatch paired with an iPhone.
Tidsramme: 1 week and 7 weeks (8 weeks max)
1 week and 7 weeks (8 weeks max)
Number of hours per day during which the participant stood and moved for at least one minute per hour. Measured by a smartwatch paired with an iPhone.
Tidsramme: 1 week and 7 weeks (8 weeks max)
1 week and 7 weeks (8 weeks max)
Time spent standing (minutes), measured by a smartwatch paired with an iPhone.
Tidsramme: 1 week and 7 weeks (8 weeks max)
1 week and 7 weeks (8 weeks max)
Maximal oxygen consumption (VO₂max), measured by a smartwatch paired with an iPhone.
Tidsramme: 1 week and 7 weeks (8 weeks max)
1 week and 7 weeks (8 weeks max)
Number of daily steps, measured by a smartwatch paired with an iPhone.
Tidsramme: 1 week and 7 weeks (8 weeks max)
1 week and 7 weeks (8 weeks max)
Changes in the number of calories burned per day Calories burned per day, are measured by a smartwatch paired with an iPhone.
Tidsramme: 1 week and 7 weeks (8 maximum)
1 week and 7 weeks (8 maximum)
Number of hospitalizations since the V1 visit
Tidsramme: 3 weeks and 7 weeks (8 maximum)
3 weeks and 7 weeks (8 maximum)
Change of residence since the V1 visit (Yes or No)
Tidsramme: 3 weeks and 7 weeks (8 maximum)
3 weeks and 7 weeks (8 maximum)
Changes in functional abilities measured by "Activities of Daily Living" (ADL) score (6 items)
Tidsramme: baseline and 7 weeks (8 weeks maximum)
_ /6 ; 0 being the worse and 6 the better
baseline and 7 weeks (8 weeks maximum)
Death (Yes or No)
Tidsramme: 3 weeks and 7 weeks (8 maximum)
3 weeks and 7 weeks (8 maximum)
Program adherence is measured by the number of completed self-rehabilitation sessions for Intervention Group
Tidsramme: 7 weeks (8 weeks maximum)
7 weeks (8 weeks maximum)
Changes in SPPB score, at V1 and V3 Short Physical Performance Battery (SPPB) score
Tidsramme: baseline and 7 weeks (8 weeks maximum)
_/12; Adding up the scores from all the tests yields an overall performance score out of 12. A score below 8 indicates a risk of sarcopenia.
baseline and 7 weeks (8 weeks maximum)
Number of falls showing signs of severity
Tidsramme: baseline, 3 weeks and 7 weeks (8 maximum)
If at least one fall met the criteria for severity, how many falls show signs of severity ?
baseline, 3 weeks and 7 weeks (8 maximum)
Changes in functional abilities measured by Instrumental Activity of Daily Living (IADL) score (4 items)
Tidsramme: baseline and 7 weeks (8 weeks maximum)
_ /4; 0 being the worse and 4 the better
baseline and 7 weeks (8 weeks maximum)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Cédric ANNWEILER, Pr., Angers Universitary Hospital (CHU)

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

5. december 2026

Primær færdiggørelse (Anslået)

22. juni 2028

Studieafslutning (Anslået)

22. juni 2028

Datoer for studieregistrering

Først indsendt

17. juli 2026

Først indsendt, der opfyldte QC-kriterier

28. juli 2026

Først opslået (Faktiske)

3. august 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. august 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

3. august 2026

Sidst verificeret

1. august 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 49RC26_0272
  • 2026-A01541-50 (Registry Identifier: ID-RCB)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner